Antioxidant activities of abietane diterpenoids isolated from Torreya nucifera leaves

Journal of Agricultural and Food Chemistry

Volumn 54, Issue 15, 2006, Pages 5369-5374

  Woo, Song Lee ^a   Kim, Ju Ryoung ^a   Han, Jong Min ^a   Jang, Ki Chang ^b   Sok, Dai Eun ^c   Jeong, Tae Sook ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b National Institute of Animal Science   (South Korea)

^c Chungnam National University   (South Korea)

Author keywords

Abietane diterpenoids; Antioxidant activity; Atherosclerosis; INOS; LDL; NO; Torreya nucifera

Indexed keywords

ABIETANE DERIVATIVE; ANTIOXIDANT; COPPER; LOW DENSITY LIPOPROTEIN;

ARTICLE; CHEMISTRY; DRUG EFFECT; ISOLATION AND PURIFICATION; LIPID PEROXIDATION; PLANT LEAF; TAXACEAE;

ANTIOXIDANTS; COPPER; DITERPENES, ABIETANE; LIPID PEROXIDATION; LIPOPROTEINS, LDL; PLANT LEAVES; TAXACEAE;

TORREYA NUCIFERA;

EID: 33746877033     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf060896c     Document Type: Article

References (36)

1. Steinberg, D.; Parthasarathy, S.; Carew, T. E.; Khoo, J. C.; Witztum, J. L. Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 1989, 320, 915-923.
2. Steinberg, D. Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime. Nat. Med. 2002, 8, 1211-1217.
3. Glass, C. K.; Witzum, J. L. Atherosclerosis: The road ahead. Cell 2001, 104, 503-516.
4. Liao, L.; Starzyk, R. M.; Granger, D. N. Molecular determinants of oxidized low-density lipoprotein-induced leukocyte adhesion and microvascular dysfunction. Arterioscler., Thromb., Vasc. Biol. 1997, 17, 437-444.
5. Dejager, S.; Mietus-Synder, M.; Pitas, R. E. Oxidized low-density lipoproteins bind to the scavenger receptor expressed by rabbit smooth muscle cells and macrophages. Arterioscler. Thromb. 1993, 13, 371-378.
6. Ross, R. Atherosclerosis - An inflammatory disease. N. Engl. J. Med. 1999, 340, 115-126.
7. Moncada, S.; Palmer, R. M.; Higgs, E. A. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991, 43, 109-142.
8. MacMicking, J.; Xie, Q. W.; Nathan, C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 1997, 15, 323-350.
9. Rice-Evans, C. A.; Miller, N. J.; Paganga, G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radical Biol. Med. 1996, 20, 933-956.
10. Ahn, B. T.; Lee, S.; Lee, S. B.; Lee, E. S.; Kim, J. G.; Bok, S. H.; Jeong, T. S. Low-density lipoprotein-antioxidant constituents of Saururus chinensis. J. Nat. Prod. 2001, 64, 1562-1564.
11. Lee, W. S.; Back, Y. I.; Kim, J. R.; Cho, K. H.; Sok, D. E.; Jeong, T. S. Antioxidant activities of a new lignan and a neolignan from Saururus chinensis. Bioorg. Med. Chem. Lett. 2004, 14, 5623-5628.
12. Lee, W. S.; Kim, J. R.; Im, K. R.; Cho, K. H.; Sok, D. E.; Jeong, T. S. Antioxidant effects of diarylheptanoid derivatives from Alnus japonica on human LDL oxidation. Planta Med. 2005, 71, 296-299.
13. Bae, K. H. The Medicinal Plants of Korea; Kyo-Hak Publishing Co. Ltd.: Seoul, 2000; p 45.
14. Harrison, L. J.; Asakawa, Y. 18-Oxoferruginol from the leaf of Torreya nucifera. Phytochemistry 1987, 26, 1211-1212.
15. Orihara, Y.; Yang, J.-W.; Komiya, N.; Koge, K.; Yoshikawa, T. Abietane diterpenoids from suspension cultured cells of Torreya nucifera var. radicans. Phytochemistry 2002, 59, 385-389.
16. Nakatani, N.; Inatani, R. Structure of rosmanol, a new antioxidant from rosemary (Rosmarinus officinalis L.). Agric. Biol. Chem. 1981, 45, 2385-2386.
17. Inatani, R.; Nakatani, N.; Fuwa, H. Antioxidative effect of the constituents of rosemary (Rosmarinus officinalis L.) and their derivatives. Agric. Biol. Chem. 1983, 47, 521-528.
18. Nakatani, N.; Inatani, R. Two antioxidative diterpenes from rosemary (Rosmarinus officinalis L.) and a revised structure for rosmanol. Agric. Biol. Chem. 1984, 48, 2081-2085.
19. Kobayashi, K.; Masako, N.; Fukushima, M.; Shiobara, Y.; Kodama, M. Antibacterial activity oif pisiferic acid and its derivatives against Gram-negative and -positive bacteria. Agric. Biol. Chem. 1988, 52, 77-83.
20. Ulubelen, A.; Öksü, S.; Kolak, U.; Birman, H.; Voelter, W. Cardioactive terpenoids and a new rearranged diterpene from Salvia syriaca. Planta Med. 2000, 66, 627-629.
21. Matsuda, H.; Murakami, T.; Yashiro, K.; Yamahara, J.; Yoshikawa, M. Antidiabetic principles of natural medicines. IV. Aldose reductase and α-glucosidase inhibitors from the roots of Salacia oblonga WALL. (Celastraceae): Structure of a new friedelane-type triterpene, kotalagenin 16-acetate. Chem. Pharm. Bull. 1999, 47, 1725-1729.
22. Tahara, A.; Shimagaki, M.; Itoh, M.; Harigaya, Y.; Onda, M. Diterpenoids. XXXVIII. Conversion of 1-abietic acid into steroidal skeletons: Formation of the D-ring (1). Chem. Pharm. Bull. 1975, 23, 3189-3202.
23. Yagi, K. Lipid Peroxides in Biology and Medicine; Yagi, K., Ed.; Academic Press: Orlando, FL, 1982; p 223.
24. Devaraj, S.; Li, D. J.; Vazquez, M.; Jialal, I. Cyclosporin A does not increase the oxidative susceptibility of low-density lipoprotein in vitro. Free Radical Biol. Med. 1999, 26, 1064-1068.
25. Gugliucci, A.; Menini, T. Three different pathways for human LDL oxidation are inhibited in vitro by water extracts of the medicinal herb Achyrocline satureoides. Life Sci. 2002, 71, 693-705.
26. Lee, J. H.; Lee, B. W.; Kim, J. H.; Jeong, T. S.; Kim, M. J.; Lee, W. S.; Park, K. H. LDL-antioxidant pterocarpans from roots of Glycine max (L.) Merr. J. Agric. Food Chem. 2006, 54, 2057-2063.
27. Lesnik, P.; Dachet, C.; Petit, L.; Moreau, M.; Griglio, S.; Brudi, P.; Chapman, M. J. Impact of a combination of a calcium antagonist and a beta-blocker on cell- and copper-mediated oxidation of LDL and on the accumulation and efflux of cholesterol in human macrophages and murine J774 cells. Arterioscler., Thromb., Vasc. Biol. 1997, 17, 979-988.
28. Bursa, S. Y.; Oleszek, W. Antioxidant and antiradical activities of flavonoids. J. Agric. Food Chem. 2001, 49, 2774-2779.
29. Fieser, L. F.; Campbell, W. P. Hydroxyl and amino derivatives of dehydroabietic acid and dehydroabietinol. J. Am. Chem. Soc. 1939, 61, 2528-2534.
30. Roshchin, V. I.; Skachkova, N. M.; Lyandres, G. V.; Maksimchuk, P. L. Carbon dioxide extract from woody verdure of the Scotch pine. Group composition and acids. Chem. Nat. Compd. (Engl. Transl.) 1988, 24, 447-452.
31. Carew, T. E.; Schwenke, D. C.; Steinberg, D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: Evidence that antioxidants in vivo can selectively inhibit low-density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidaemic rabbit. Proc. Natl. Acad. Sci. U.S.A. 1987, 84, 7725-7729.
32. Kuzuya, M.; Kuzuya, F. Probucol as an antioxidant and antiatherogenic drug. Free Radical Biol. Med. 1993, 14, 67-77.
33. Esterbauer, H.; Stiegl, G.; Puhl, H.; Rotheneder, M. Continuous monitoring of in vitro oxidation of human low-density lipoprotein. Free Radical Res. Commun. 1989, 6, 67-75.
34. Tanaka, K.; Iguchi, H.; Taketani, S.; Nakata, R.; Tokumaru, S.; Sugimoto, T.; Kojo, S. Facial degradation of apolipoprotein B by radical reactions and the presence of cleaved proteins in serum. J. Biochem. 1999, 125, 173-176.
35. Heinecke, J. W.; Baker, L.; Rosen, H.; Chait, A. Iron and copper promote modification of low-density lipoprotein by human arterial smooth muscle cells in culture. J. Clin. Invest. 1984, 74, 1890-1894.
36. Steinbrecher, U. P.; Parthasarathy, S.; Leake, D. S.; Witztum, J. L.; Steinberg, D. Modification of low-density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low-density lipoprotein phospholipids. Proc. Natl. Acad. Sci. U.S.A. 1984, 81, 3883-3887.